| Brokerage Reports (Showing 1 to 10 of 10) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 17-Nov-09 | Thomson StreetEvents | N/A | FRX - Event Transcript of Forest Laboratories, Inc. conference call, Nov. 17, 2009 / 10:25am ET | 8 | $75 | | | View Abstract |
| 17-Nov-09 | Thomson StreetEvents | N/A | FRX - Event Transcript of Forest Laboratories, Inc. conference call, Nov. 12, 2009 / 1:30pm ET | 8 | $75 | | | View Abstract |
| 3-Nov-09 | Collins Stewart LLC | Louise Chen | Positive Phase III CC Data For Linaclotide Is Good for FRX | 3 | $10 | | | View Abstract |
| 28-Oct-09 | Collins Stewart LLC | Louise Chen | Positive Phase IIb Cariprazine Data Is Good For FRX; Reiterating Buy | 3 | $10 | | | View Abstract |
| 20-Oct-09 | Thomson StreetEvents | N/A | FRX - Q2 2010 Forest Laboratories, Inc. Earnings Conference Call | 22 | $75 | | | View Abstract |
| 20-Oct-09 | Collins Stewart LLC | Louise Chen | In-Line F2Q10, New Products and Pipeline Underappreciated, Buy | 13 | $50 | | | View Abstract |
| 20-Oct-09 | Thomson StreetEvents | N/A | FRX - Event Brief of Forest Laboratories, Inc. conference call, Oct. 20, 2009 / 10:00am ET | 7 | $75 | | | View Abstract |
| 20-Oct-09 | Thomson StreetEvents | N/A | FRX - Event Transcript of Forest Laboratories, Inc. conference call, Oct. 20, 2009 / 10:00am ET | 29 | $75 | | | View Abstract |
| 16-Oct-09 | Collins Stewart LLC | Louise Chen | November 2009 Stock Catalysts | 22 | $75 | | | View Abstract |
| 15-Oct-09 | Collins Stewart LLC | Louise Chen | Key Takeaways From IMS Review of Worldwide Pharma Market in 2010 | 8 | $25 | | | View Abstract |